✦ LIBER ✦

P-139 P53 or Her2/neu as prognostic factors in advanced non-small cell lung cancer (NSCLC) treated with paclitaxel

✍ Scribed by Yumuk, P.; Turhal, N.; Ahiskali, R.; Gumus, M.; Hatabay, N.; Turken, O.; Ozkan, A.; Salepci, T.; Aliustaoglu, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-491 Palliative chemotherapy (QT) and p

✍ Guerreroero Zotano, A.; Pellin Ariño, L.; Molina Saera, J.; Palomar Abad, L.; Po 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Multi-center study with paclitaxel (P)/c

✍ Glorieux, P; Ortmanns, P; Marien, S; Degives, R; Degraeve, D; Potvin, M; Grauwel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Prognostic value of immunohistochemical

✍ Helen Han; Rodney J. Landreneau; Tibetha S. Santucci; Ming Y. Tung; Robin S. Mac 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 148 KB

P-206 Comorbidity assessment in frail pa

✍ Juan, Oscar; Casany, Rosa; Albert, Ana; Caranyana, Vicente; Campos, Juan Manuel; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 233 KB

P-19 Gemcitabine-vinorelbine as second l

✍ Montalar, Joaquin; López-Tendero, Pedro; Diaz-Bedveridge, Robert; Calderero, Ver 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Telomerase activity and serum levels of

✍ Tomasz Targowski; Karina Jahnz-Rozyk; Witold Owczarek; Alicja Raczka; Pawel Jand 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 336 KB